Open AccessElevated interleukin-6 levels are associated with impaired outcome in cardiac transthyretin amyloidosis
Author(s) -
Selina Hein,
Maximilian Knoll,
Fabian aus dem Siepen,
Jennifer Furkel,
Stefan Schönland,
Ute Hegenbart,
Hugo A. Katus,
Arnt V. Kristen,
Mathias Konstandin
Publication year - 2021
Publication title -
world journal of cardiology
Language(s) - English
Resource type - Journals
ISSN - 1949-8462
DOI - 10.4330/wjc.v13.i3.55
Subject(s) - medicine , transthyretin , amyloidosis , cardiac amyloidosis , interleukin , gastroenterology , cardiology , bioinformatics , cytokine , biology
Elevated interleukin (IL)-6-levels have been described in familial variant transthyretin amyloidosis (ATTRv) associated polyneuropathy and heart failure. However, IL-6 in cardiac ATTR amyloidosis (ATTR-CM) and its prognostic value have not been investigated yet.